Key points are not available for this paper at this time.
Design
Editorial
Highlights the potential of combining newer pharmacologic approaches, such as prostaglandin chemistry, with surgical procedures for managing atherosclerosis.
Vascular surgeons have not paid enough attention to all of the host factors responsible for the pathogenesis of atherosclerosis. With a clearer understanding of the role of platelets and endothelial cells, improved results and better long-term palliation can be realized by combining newer pharmacologic approaches with well-established surgical procedures. Prostaglandin chemistry research may provide promising therapeutic adjuncts to current techniques for managing atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Rodger E. Weismann (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: